Successful treatment of refractory pure red cell aplasia in major ABO-mismatched allogeneic hematopoietic stem cell transplant with single agent Ibrutinib.

Authors :: Arslan S
Ali H
Mei M
Marcucci G
Forman S
Nakamura R
Stein A
Al Malki MM
Source :: Bone marrow transplantation [Bone Marrow Transplant] 2022 May; Vol. 57 (5), pp. 830-833. Date of Electronic Publication: 2022 Feb 22.
Publication Year :: 2022

Subjects :: ABO Blood-Group System
Adenine analogs & derivatives
Blood Group Incompatibility
Humans
Piperidines
Hematopoietic Stem Cell Transplantation
Red-Cell Aplasia, Pure drug therapy
Red-Cell Aplasia, Pure etiology

Full Text Access

Tools